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CHAPTER 1

INTRODUCTION

Statement of the problem

The primary goal of this project 1s to determine the formal potentials of
hemoglobin and two cross-linked hemoglobins. The formal potential will be determined
by the use of spectroelectrochemical technique. This technique is beneficial for
biochemical research because it employs a small amount of solution for obtaining both
spectroscopic and electrochemical parameters and properties of redox processes.
Determination of the formal potential of hemoglobin and cross-linked hemoglobin
could give an insight into the electron transfer reactions of hemoglobin and cross-linked
hemoglobin and how cross-linking affects the accessibility of the heme groups and its
formal potential.
The goal of chemical modification and cross-linking of all free hemoglobin is to
decrease the oxygen affinity of the free hemoglobin, to prevent its dissociation into a.{3
dimers, to achieve a molecular engineering which would produce an active stabilized
protein, and to develop a suitable hemoglobin derivative capable of clinical use as a
blood

substitute.

Spectroelectrochemical

technique

could

be

qualitative/quantitative analysis of hemoglobin and cross-linked hemoglobin.

used

for

2

Hemoglobin Background
Hemoglobin, a tetramer with four heme moieties (Fig .1), functions as the oxygen
carrying protein in erythrocytes (red blood cells). Hemoglobin binds molecular oxygen
to its heme irons at the lungs and delivers it to the various tissues throughout the body.
It also transports carbon dioxide, a by-product of oxidation from the tissues back to the
lungs to be exhaled. 1-4
The human hemoglobin molecule has four chains: two identical a chains, each
with 141 amino acids residues with molecular weight of 15, 126 daltons, and two identical
(3 chains, each with 146 amino acid residues with molecular weight of 15,867 daltons.

Each heme group has a molecular weight of 616 daltons. Thus, a molecule of human
hemoglobin tetramer has a molecular weight of 64,450 daltons. 1 In humans, several
hemoglobins occur normally:

A0 (main component of human red cells), F (fetal

hemoglobin), and A 2 (minor component of human red cells). They all contain four
subunits but differ in their primary structure (amino acid sequence) of the globin. 2 -5
The hemoglobin molecule has a twofold axis of symmetry. Each dimer contains
one a and (3 chain, which are held tightly together by atomic interactions. Buried in the
midst of the globin a and (3 chains are the four heme groups containing ferrous ion,
protected from oxidation by a hydrophobic environment. 5 The iron atom in the heme
group can be in the ferrous ( +2) or the ferric ( +3) oxidation state, and the
corresponding forms of hemoglobin are called ferrohemoglobin and ferrihemoglobin (also
known as methemoglobin). Methemoglobin, containing the

+ 3 oxidation state of iron,

cannot bind oxygen. Only ferrohemoglobin can bind oxygen. 6

3

Figure 1. Structure of Heme group

5
Hemoglobin (ferro) exists in two forms: deoxyhemoglobin (without oxygen), and
oxyhemoglobin (with oxygen). Deoxyhemoglobin assumes the tense (T) conformation and
oxyhemoglobin assumes the relaxed (R) conformation. The T state is physically more
constrained than the R state. The stability of the T state decreases with successive
oxygenation of the heme group, and as a result the molecules undergo a transition to the
R state with the release of the constraints and an increase in oxygen affinity .5 The

principal physiologic effectors (regulators) of the binding of oxygen by hemoglobin
within the red cells are H+, 2,3-bisphosphoglycerate (2,3-BPG), and CO2 • Other
regulators, such as c1- and adenosine triphosphate (ATP), also decrease oxygen affinity,
but their physiological roles are minor. 5 These regulators affect the oxygen binding
properties of hemoglobin by binding to sites on the protein far from where oxygen is
bound. 5•6

The hemoglobin molecule acts in a cooperative manner in binding and

releasing molecular oxygen. The binding of an oxygen molecule to any of the heme
groups of hemoglobin is affected by the state of the other three heme groups. The first
oxygen binds weakly to heme, the second and the third oxygens bind more strongly, and
the last oxygen binds with two or three orders of magnitude greater than the first
oxygen. 1
Hemoglobin in solution has the ability to bind oxygen. In theory, it could be used
in place of red blood cells. 5 Hemoglobin as a blood substitute has the following
advantages over whole blood: it does not carry viral infections, it has a longer shelf-life,
and there is no need for blood type matching. 5 However, free hemoglobin in solution has
a higher oxygen affinity because outside the red cell the normal allosteric effector, 2,3-

6

BPG, is absent. Free hemoglobin dissociates into half-molecules (a/3 dimers) that are
rapidly removed from the circulation by the kidney after filtration in the glomerulus.
Once filtered, a high concentration of protein in the renal tubules can cause tubular
obstruction and consequent renal failure. 5 Hence, modification of hemoglobin is
necessary for improving these disadvantages inherent in cell-free hemoglobin. 5
Cross-linking of Hemoglobin

Various chemical reagents have been used for the chemical modification and
cross-linking

of hemoglobin.

These

reagents

are:

acetaldehyde,

mono-(3,5-

dibromosalicy l)fumarate, 2-nor-2-formy lpyridoxal 5 '-phosphate (NFPLP), bis-(3, 5dibromosalicy l)fumarate, etc. 5
All these reagents cross-link hemoglobin intermolecularly or intramolecularly at
different sites and involve different amino residues of the globin. 5 When hemoglobin is
chemically modified, the T to R transition is altered; this alteration manifests itself in
a reduced

Bohr effect (effect of H+).

Bis-(3,5-dibromosalicyl) fumarate (DBSF) can be used to cross-link hemoglobin.
The product of the cross-linking depends upon the type of hemoglobin used. {3{3
hemoglobin results from using oxyhemoglobin and aa hemoglobin results from using
deoxyhemoglobin. DBSF reacts selectively with oxyhemoglobin to cross-link the {3 chains
between lysine-82/3 1 and lysine-82/3 2 within the 2,3-diphosphoglycerate binding site. 7-9
DBSF also reacts selectively with deoxyhemoglobin to cross-link the a chains. The crosslinking lies between lysine-99a 1 and lysine-99a2 spanning the central cavity of the
tetramer. Lysine-99a 1 and lysine-99a2 are located within a cluster of charged amino acid

7

residues very near the middle of the hemoglobin molecules. 7 It has been found that
DBSF cross-linked hemoglobin has increased thermal stability. 5 Electrochemical and
spectroelectrochemical studies of

lysine (99)ai-lysine(99)a2 and lysine (82)/1 1-lysine

(82)(32 and cross-linked hemoglobin will be made in this Project.

Hemoglobin Electrochemistry

Hemoglobin possesses functional groups (heme groups and amino residues) that
can be readily oxidized or reduced by chemical redox agents. But, it is difficult for
hemoglobin to undergo facile oxidation or reduction at electrodes. The reasons for this
behavior are ascribed to hemoglobin's extended three-dimensional structure which results
in inaccessibility of the electroactive center, and its adsorption onto and subsequent
passivation of the electrode surface. 10- 17 Hemoglobin exhibits a very slow rate of electron
transfer so that no useful currents are observed at conventional electrodes, even with the
application of relatively large overpotentials. 18
An approach that has been successfully applied to obtain electrochemical
information concerning hemoglobin involve the use of low molecular weight "mediator
titrant". These mediator titrant compounds (methylene blue, 19 thioneine, 20 toluidine blue, 21
and janus green, 22 brilliant cresyl blue23 , and bromopyrogal red 24 ) are either added to the
solution of hemoglobin or the working electrode is chemically modified with one or two
of these compounds. When these mediator compounds are added to hemoglobin in low
concentration, they serve as electron transfer intermediaries by carrying out the chemical
oxidation or reduction of hemoglobin away from the electrode surface. The mediator
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compound is electrolyzed at its characteristic redox potential and in a succeeding
chemical step effects the desired redox conversion of hemoglobin. 21 •25
The results obtained from using chemically modified electrodes (CME) show that
hemoglobin undergoes a quasi-reversible electrochemical response to an applied potential
with reaction rates of the oxidation being much slower than the reduction. 19-24 The only
exception is at a Janus Green modified platinum electrode, which shows the opposite
behavior. 22 The electrochemical behavior of hemoglobin is strongly dependent upon pH,
electrolyte, and other solution conditions. 18
Hiroyuki Ohno et al. applied solid state electrochemistry to study hemoglobin by
casting polyethylene oxide (PEO)-modified hemoglobin onto an indium tin oxide (ITO)
electrode. 26 They found out that PEO-hemoglobin was electrochemically reduced and
oxidized reversibly in PEO oligomers or poly (oligo-(oxyethylene) methacrylate)
containing KCI. Higher supporting electrolyte concentration and more negative potential
were effective for faster redox reactions. 26-30

TECHNIQUES

Various electrochemical methods had been used

m the literature to study

hemoglobin. These methods include cyclic voltammetry (CV), single potential
chronoabsorptometry (SPA/CA), derivative cyclic voltabsorptometry (DCVA), double
potential step chronoabsorptometry, polarography, and spectroelectrochemical methods.
In all these methods, the working electrode is either modified with mediator/promoter
compounds or is unmodified. Some methods have mediator compounds added to the

9

solution to facilitate electron transfer.

Cyclic Voltammetry

Cyclic voltammetry (CV) is a technique for measuring the formal potential of a
half-reaction when both reduced and oxidized forms are stable enough for a
voltammogram (current-potential curve) to be obtained. 31 It measures the current that
flows at an electrode as a function of the potential applied to the electrode. 32
In CV, the potential of a stationary working electrode is changed linearly with
time starting from a potential where no electrode reaction occurs and moving to a
potential where reduction or oxidation of the substrate occurs. For an oxidized substrate,
the potential starts from a value more positive to its formal potential and is then scanned
in the negative direction. As the potential approaches the formal potential, a faradaic
current is observed, which is due to the reduction of the substrate at the electrode
surface. Eventually, the electrode surface region is depleted in oxidized compounds and
a diffusion layer forms, causing the current to tail off, forming a peak shape. The
direction of the potential scan can be reversed and scanned positive.

Upon scanning

positive, faradaic current of opposite sign appears as the substrate is regenerated through
an oxidation reaction. The time scale of the experiment is controlled by the scan (or
sweep) rate. A supporting electrolyte is present to repress migration of charged reactants
and products. The CV has several distinguishing characteristics (Fig. 2): the cathodic
(Epc) and anodic (ErJ peak potentials, the cathodic (ire) and anodic (ipa) peak currents, and
the half-wave potential (E 112). 31 For a simple reversible, redox reaction, the potential of

10

Figure 2. Example of a typical cyclic voltammogram of 6 mM K3FE(CN) 6 in 1.0 M
KNO 3 (adapted from Kissinger and Heineman. 41 )
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the reduction Ere differs from the potential of the oxidation peak Era in the reverse scan
by 59/n mV. 32 The formal potential, E 0 lies midway between Epcand Era·
The peak current for a reversible system is described by the Randles-Sevcik
equation.
ip = 2.69

X

105 n312 A D 112 v112

(1)

= peak current

Where ir
A

=

area of the electrode in cm2

n

=

number of electrons transferred

D

=

diffusion coefficient in cm2 / s

C*

= concentration in mol/cm3

v

c·

= scan rate, V/s

SPECTROELECTROCHEMISTRY

Spectroelectrochemistry is the combination of two quite different techniques,
spectroscopy and electrochemistry. It is used to study the redox chemistry of inorganic,
organic, and biological molecules. Oxidation states are changed electrochemically by
addition or removal of electrons at an electrode while spectral measurements are made
simultaneously on the solution adjacent to the electrode. 33 -38 The most frequently used
optical technique in spectroelectrochemistry is absorption spectroscopy in the ultraviolet,
visible or infrared region.
The most important instrumental part of thin-layer spectroelectrochemical
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technique is the thin-layer cell. The most commonly used cell is the optically transparent
thin-layer electrochemical cell (OTTLE). 33 The working electrode could be an optically
transparent electrode (OTE). OTE can consist of a very thin transparent conductive film
of metal or metal oxide such as indium oxide deposited on a transparent substrate (glass
or quartz), a gold minigrid, a platinum minigrid, or platinum gauze. In OTTLE, the
optical beam axis is perpendicular to the electrode surface. Another type of thin-layer
spectroelectrochemical cell being used is the long optical path thin-layer electrochemical
cell (LOPTLC). It has the similar working electrode as OTTLE but, its optical beam
axis is parallel to the electrode surface. 33
In an ideal thin-layer cell, the peak potentials (cathodic and anodic), for cyclic
voltammogram (CV), current-potential (i-E) curves should coincide with zero peak
separation and both peak potentials should correspond to the formal redox potential
E 0 • 34 ·39 The integrated charges under each of the i-E curves for the anodic and cathodic
scans, Qa and Qc, should be equal. Equal values of Qa and Qc indicate retention of the
solution species within the electrolysis volume and it

also assumes that the

concentrations of the oxidized and reduced species are uniform throughout the thin-layer
cell cavity. 34 •39
To approach these conditions experimentally, the thickness of the cell cavity has
to be as small as possible in order to minimize concentration gradients. The sweep rate
should be as small as possible also. However, the smaller the thickness of the cell cavity,
the larger the potential gradient buildup across the surface of the working electrode. 40
For a reversible reaction in a thin-layer cell, the peak current occurs when E

=

14
E°' and is given by equation 2. 40

iP = =-=------'-~on2F 2vVC *

(2)

4RT

where C 0 •

= bulk solution concentration in mol.

cm-3

V = cell volume in liter
v

=

scan rate in mV/s

T

=

temperature in Kelvin

F

=

Faraday's constant in coulombs

n

=

no of electrons transferred

R = gas constant in J K 1 moi- 1

iP = peak current in Amperes
A typical scan voltammogram in a thin layer cell is shown in Figure 3.
Thin-layer spectroelectrochemistry can be used to obtain spectra information at
fixed wavelength(s) (usually peak absorbance for the sample), formal reduction potentials
(E0 ' ) , and electron transfer number (n) of redox couples. The redox couple is converted
incrementally from one oxidation state to another by a series of applied potentials. At
each applied potential, the absorbance is monitored as a function of time. After steady
state absorbance is obtained, the potential is then stepped to another potential and the
corresponding

absorbance

values

of oxidized/reduced species

are

determined

spectroscopically.
The redox potential of a thin layer solution is adjusted precisely by the applied
potential as determined for the reversible system,

15

Figure 3. Shows a theoretical cyclic current-potential curve for a reversible reaction in
a thin layer cell using equation 2. (adapted from Bard and Faulkner. 40 )
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0

+

~

e

E = E

Where

0

R

+

'

=

n

0.059
n

by the Nernst Equation

log IQl

(4)

[R]

number of electrons transferred
oxidized species

[ 0 ]

[R]

(3)

=

reduced species

E

=

applied potential

E0 '

=

formal reduction potential

Although the applied potential, E, controls the ratio [0]/[R] at the electrode
surface, the ratio in the thin solution layer quickly adjusts to the same ratio by
electrolysis. 42-44
Based on the Nernst Equation, a Nerstian plot of applied potential vs log [O]/[R]
is a straight line with a slope of 0.059/n and an intercept equal to E0 ' value. The ratio
of [O]/[R] can be calculated from the values obtained from the maximum absorbance
peaks and is given by the equation:
log IQl

=

[R]

Where A 1
A2
A3

=

=

absorbance of the reduced form

steady-state absorbance at any applied potential

= absorbance

of the oxidized form

CHAPTER 2

EXPERIMENTAL METHODS
EXPERIMENTAL
General Methods
Instruments

An EG &G Princeton Applied Research Company Potentiostat/Galvanostat model
273 with a RE0091 X-Y recorder or Versastat potentiostat with an IBM HP 7371 plotter
was used to obtain potential readings. Potentials were measured against a Saturated
Calomel Electrode (SCE), (Fisher Scientific Company). The Ultra-Violet/Visible
experiments

were

performed

on

a

Hewlett

Packard

8452A

diode

Array

Spectrophotometer (equipped with an Epson FX-80 printer, and a Gateway 2000
480DX2/50 PC computer with Hewlett Packard HP89531A operating software). The
temperature of the sample in the semi-microcell inside the spectrophotometer cell holder
was controlled by VWR Scientific model 1167 Digital programmable temperature
controller. Reagent weighings were performed on a Sartorius analytical balance. pH
measurements were made on Jenco 672 digital pH/MV /Temp meter. Sonication of the
working electrode was performed on Branson 1200 Ultrasonic cleaners. Polishing of the
electrodes were done on a Buchler Ecomet III polisher. Four-neck electrochemical cells
were used for the cyclic voltammetry experiments.
18
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Chemicals and Samples
Sodium ferricyanide and potassium ferricyanide (City Chemical Corporation),
potassium chloride and sodium chloride (Aldrich), anhydrous sodium phosphate (E-K
Industries), monobasic dihydrate sodium phosphate and sodium hydroxide (Fisher
Scientific Company) were used as received.
Hemoglobin, lysine (99)aclysine (99)a2 cross-linked hemoglobin, and lysine
(82)/3 1-lysine (82)/3 2 cross-linked hemoglobin were obtained from Dr. K. Olsen's
Laboratory. Samples were refrigerated at 4°C at all times except during experimentation.

Spectroelectrochemical Analysis
Instrumental set-up
A 4mm

optical pathlength semi-micro fluorescence cell (Hellman cell Inc.)

served as both the electrochemical and spectroscopic cell. Indium oxide coated glass was
used as a spacer (3 .19mm thick) inside the cell to make the cell a thin-layer cell. The
electrochemical component of the system are made up of a potentiostat, a recorder, and
three electrodes. A Platinum gauze, Platinum wire, (D. F. Goldsmith Chemical & Metal
Corporation Evanston IL), Saturated Calomel Electrode (SCE) were used as the working,
counter, and reference electrodes, respectively. The semi-microcell was placed in the
optical path of the Hewlett Packard 8452A diode array spectrophotometer in such a way
that the optical beam axis is perpendicular to the electrode surface/solution.
The incoming optical light passes through the cell cavity, which is defined by the
polished optically transparent walls of the cell, the working electrode, counter electrode,

20
spacer, and the solution layer thickness estimated to be 0.81mm (0.295mm is the
electrolyzed layer and 0.515mm houses the counterelectrode and the salt bridge for the
reference electrode).
Figure 4 shows the schematic diagram of the instrumental setup.

Preparation of samples

Hemoglobin and cross-linked hemoglobins eluted from DEAE-sephadex A-50 with
pH 8.5 tris-buffer were dialyzed in the refrigerator for 24 hours in a dialysis bag with
phosphate buffer. After dialysis, the hemoglobin and its cross-linked products were ready
for spectroelectrochemical studies. They were refrigerated at 4°C when not in use. The
O. lM phosphate buffer system consisted of sodium phosphate, monobasic dihydrate
sodium phosphate, sodium hydroxide, which was usually added to adjust the pH of the
system to the desired pH of 7. 0, and O. 1 potassium chloride. The phosphate buffer
served as the electrolyte and the solvent for the spectroelectrochemical studies.
During experimentation, the temperature of hemoglobin and its cross-linked
products were kept at 25°C with the aid of a VWR Digital Programmable temperature
controller.

Experimental Procedure

The platinum (Pt) gauze, the Pt wire, and the spacer were washed and sonicated
in between sets of experimental determinations to ensure that any adsorbed
molecules/particles were desorbed and rinsed away. This procedure ensured a clean,

21
Figure 4. Schematic diagram of the spectroelectrochemical setup: (a) Platinum gauze;
(b) spacer; (c) salt bridge; (d) Platinum wire; (e) semi-microcell.
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fresh, and approximately constant electrode surface area. A salt bridge was made by
heat swelling of Agar gel and KCl in water. The resulting gel was then placed inside a
small diameter rubber tubing while hot and allowed to solidify. When not in use, the salt
bridge was stored in a solution of KCI. The salt bridge was connected to the narrow end
of a glass pipette, the upper part of which was connected to a small plastic container
with a hole drilled at the bottom of it. This home-made salt bridge system housed the
SCE electrode, and it also served as the connector of the solution under investigation and
the referenced solution (the same in all respect as the sample solution).
The cleaned electrodes, the rubber tube part of the salt bridge system, and the
spacer were placed in a semi-microcell, which in turn, was placed inside the
spectrophotometer cellholder. Once in place, the cell was filled to the top with the
sample via a 5ml syringe. The Pt Gauze working electrode, the Platinum wire
counterelectrode, and the reference electrode were then connected to the potentiostat.
At the start of each set of experiments, the absorbance of the semi-mirocell with
its contents, and the phosphate buffer was scan as a blank. Running of the blank was
done every two hours to ensure the stability of the UV-VS Spectrophotometer. The
spectrum was taken while the spectrophotometer was in the absorbance-wavelength mode
with the potentiostat on and with a specified applied potential. Subsequent spectra were
taken when a fairly constant absorbance was obtained for the applied potential. This
usually was 120 seconds for the K3Fe(CN) 6 system. The potential was then stepped up
to another value and the spectrum taken when a constant absorbance value was obtained.
Before each potential step, the system was kept at a more positive potential (for example,

24
at 0.50V for K3Fe(CN) 6), to allow the thin-layer solution to contain only the oxidized
form. The spectrum was printed after every determination.

Electrochemical Experimental Setup

For each experiment, the solution was purged with N2 gas before use. Potentiostat
parameters were set as follows: scan rate 4mV/s, unless otherwise specified, low pass
filters, reference 0.24150 SCE, potential windows of +0.50V to -0.20V for Fe(CN)/
experiments. The Fe(CN)/ solution inside the four-necked electrochemical cell was
purged for 10 minutes and a blanket of N2 gas was maintained over the surface of the
solution to avoid oxygen interference and gas stream disturbance during the entire
experimental period. The three electrodes (Pt wires, SCE, as auxiliary, working,
reference electrodes respectively) were inserted into the solution and connected to their
corresponding cables on the Versastat potentiostat/Par 273 Potentiostat. All the necessary
switches were turned on and the experiment was started at this point. Model 250
electrochemical analysis software does all the current versus potential output adjustments
automatically for the Versastat potentiostat.

Concentration Determination

The concentration of hemoglobin and cross-linked hemoglobin were determined
using the spectrophotometer. The absorbance peak at 542nm was used to calculate the
concentration of oxyhemoglobin when the solution is essentially oxyhemoglobin. The
absorbance peak at 406nm was used to calculate the concentration of methemoglobin

25
when the solution is essentially methemoglobin using the Beer-Lambert equation.
A= e b c

(3)

Where A = absorbance at 542nm
e = molar absorptivity in L mo1- 1 cm- 1
b = optical pathlength in cm
c = concentration in moles/liter
Figures 5, 6 and 7 show the spectra of hemoglobin, aa hemoglobin, and

pp

hemoglobin respectively. From the spectra it appears that there are no significant
differences between their spectra.

26
Figure 5. Spectrum of 4.429 micromolar hemoglobin in pH 7.0, 0.10M phosphate +

0.1 OM KCI buffer system.
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Figure 6. Spectrum of 2.017 micromolar aa hemoglobin in pH 7.0, 0.10M phosphate

+ 0.10M KCl buffer system.
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Figure 7. Spectrum of 6.297 micromolar

+ 0.1 OM KCI buffer system.

00 hemoglobin

in pH 7.0, 0.10M phosphate
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CHAPTER 3
RESULTS AND DISCUSSION

Cyclic Voltammetry

A spectroelectrochemical system has been designed to study the electrochemical
behavior of hemoglobin and cross-linked hemoglobin. K3Fe(CN) 6 , a well studied
compound,

was

used

as

a test

system to

study

the

electrochemical

and

spectroelectrochemical behavior of the cell before its application to hemoglobin and
cross-linked hemoglobin.
Figure 8 shows the CV current-potential curve obtained for a solution of 5.0mM
K3Fe(CN) 6 in I.OM KCl at a conventional electrochemical cell with Pt wire as the
working electrode. The electron-transfer process of Fe(CN)/ is quasi-reversible. This
phenomenon is characterised by an increase in the difference between the oxidation and
reduction peaks as scan rate increases. 31 · 40 The heterogenous electron-transfer kinetics of
Fe3 + /Fe2+ redox system depend on the electrode material, pretreatment of the electrode
surface, and solution condition. 33
Figure 9 shows the CV obtained for 5.0mM K3Fe(CN) 6 in I.OM KCl in the
homemade spectroelectrochemical cell (OTTLE). The cathodic and anodic peak currents
have equal values (0.60mA) with opposite signs. The charges under the integrated area
are approximately equal. A half-wave potential of 0.208V Vs SCE obtained from the
32

33
Figure 8. Cyclic voltammogram current-potential curve of 5.0mM K3Fe(CN) 6 in 1.0M
KCl at a conventional electrochemical cell. Scan rate of 4 mV/s.
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Figure 9. Cyclic voltammogram current-potential curve of 5.0mM K3Fe(CN) 6 in I.OM
KCI in the house made spectroelectrochemical cell (OTTLE). Scan rate of lmV/s.
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midpiont of the difference between the cathodic peak and the anodic peak currents is in
close agreement with the value reported in the literature. 33 The cyclic voltammetric
obtained shows a large peak separation. This behavior might be due to non-uniform
concentration of the oxidized and reduced species throughout the thin-layer cell cavity
(a common problem with thin layer cells). The effect of which might result in bounded
diffusion in the cell, uncompensated iR drop, and potential gradient buildup across the
surface of the working electrode. 39 • 40

Spectroelectrochemistry of ferricyanide
The wavelength of the maximum absorbance for 5. OmM K3Fe(CN) 6 in 1. OM KCl
is 420nm (Fig. 10) and is chosen as the characteristic wavelength at which to monitor
reduction.
Figure 11 shows the plot of absorbance against wavelength for 5. OmM K3Fe(CN) 6
m 1. OM KCl using the spectroelectrochemical cell during a sequence of applied
potentials. For applied potential of O.289V to O.239V, the absorbance peaks were
relatively constant (peak (a)). As more negative potential was applied , the peaks height
decrease reaching the lowest value at applied potential of -O.109V. Assuming that
Nernstian equilibrium is attained within the cell cavity, the absorbance values measured
at various applied potentials can be used for the determination of E0 ' and n for the redox
couple using equation 4 (page 17). The ratio of [Fe(CN)/V[Fe(CN) 64-] is controlled by
the value of

EappI..

Figure 12 shows the plot of absorbance against potential for 5.OmM K3Fe(CN) 6

38

Figure 10. Absorption spectrum of 5.0mM K3Fe(CN) 6 in 1.0M KCl with the maximum
absorbance at 420nm.
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Figure 11. Absorption spectrum of 5.0mM K3Fe(CN) 6 in 1.0M KCl at several applied
potentials: (a) 0.289V, (b) 0.239V, (c) 0.219V, (d) 0.179V, (e) 0.159V,
(t) 0.098V, (g) -0.0lOV, (h) -0.109V.
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in l.0M KCl at 420nm wavelength. The absorbance values for the cathodic potential
sweeps remain relatively constant at
0.391 V, since the ratio of

EappI.

values from an initial potential of 0.491 V to

[Fe(CN)/]/[Fe(CN)/] is essentially zero. As

E

0
•

is

approached, the absorbance decreases due to the reduction of Fe(CN)l to Fe(CN)/-.
The absorbance value falls to a very low constant value when the reduction of Fe(CN)l
to Fe(CN) 64- has been completed within the electrolysis volume.
Figure 13 shows the Nernstian plot for the reduction of Fe(CN)/ to Fe(CN)/.
The intercept of the plot on the y-axis is equal to the E0 ' value and the slope gives the
number of electrons transferred. The E0 ' value from the intercept is 0.197V. This value
compares favorably with the value of 0.208V obtained from the thin-layer cyclic
voltammogram (Fig. 9). The expected slope from the Nernstian equation should be
0.059, but the value obtained from the plot is 0.0774. This slope gave an value of 0. 762
instead of the expected value of 1.
Fig. 14 shows the plot of absorbance against time for the reduction of Fe(CN)l
to Fe(CN) 64- from potential step of 0.509V to -0.200V at wavelength of 420nm. The
reduction is essentially 94% complete in 150 seconds.
Fig. 15 Shows the plot of absorbance against time for the oxidation of Fe(CN)/
to Fe(CN)t from potential step of -0.200V to 0.509V at wavelength of 420nm.
Oxidation is 92 % complete after 180 seconds.
Fig. 16 shows the voltabsorptometric plot for the reduction of Fe(CN)/ to Fe(CN)64from 0.509V to -0.200V, scan rate of lmV/s monitored at 420nm wavelength.
Since the time of electrolysis can be obtained from (Figs. 14-16), we can calculate
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Figure 12.

Plot of absorbance against potential at 420nm wavelength for

K3Fe(CN) 6 in 1.0M KCl.

5.0mM
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Figure 13.

Nernstian plot for the reduction of 5.0mM K3Fe(CN) 6 in 1.0M KCl

monitored at 420nm wavelength.
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Figure 14. Plot of absorbance against time for the reduction of Fe(CN)t to Fe(CN) 64from potential step of 0.509V to -0.200V at wavelength of 420nm.
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Figure 15. Plot of absorbance against time for the oxidation of Fe(CN) 64- to Fe(CN)l
from potential step of -0.200V to 0.509V at wavelength of 420nm.
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Figure 16. Voltabsorptometric plot for the reduction of Fe(CN)l to Fe(CN)t from
0.509V to -0.200V, scan rate of lmV/s monitored at 420nm wavelength.
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the thickness of the thin layer cell.
The calculated value is 0.355mm. When this value is compared with the estimated value
of 0.295mm obtained from the cell dimension, one can assume that there is bounded
diffusion in the cell during electrolysis.
Figures 9 through 16 show that spectroelectrochemical experiments can be carried
out using the newly constructed spectroelectrochemical cell. The results obtained show
that ferricyanide can be reversibly reduced and oxidized using the system. The E value
0

'

obtained compares favorably with the literature value.

Cyclic Voltammetry of Hemoglobin

Figures 17, 18 and 19 show the cyclic voltammograms of hemoglobin,

aa

hemoglobin, and {3(3 hemoglobin respectively. From the cyclic voltammograms, no
useful currents were observed. These observations confirm the literature's ascertion that
hemoglobin exhibits such slow rates of electron transfer that no useful currents are
observed at conventional electrodes, even with the application of relatively large
overpotentials. 10, 18-24 Hence, it can be deduced that aa, and {3(3 cross-linked hemoglobin
behave like uncrosslinked hemoglobin in this respect. It also shows that cross-linking
does not improve or enhance hemoglobin's electrochemical behavior towards
conventional electrodes.
Figures 20, 21 and 22 show the plot of absorbance against time for the reduction
of hemoglobin, aa and {3(3 cross-linked hemoglobin respectively. For the reduction
process the potential was stepped from 0.589 V to -0.509 V. It is interesting to note
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Figure 17. Cyclic voltarnmogram of 45.7 micromolar hemoglobin in pH 7.0, 0.10M
phosphate

+ 0.10M KCI buffer system.
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Figure 18. Cyclic voltammogram of 45.7 micromolar aa hemoglobin in pH 7.0, 0. lOM
phosphate

+

0.10M KCI buffer system.
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Figure 19. Cyclic voltammogram of 45. 7 micromolar /3/3 hemoglobin in pH 7.0, 0.10M
phosphate

+ 0.10M KCI buffer system.
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Figure 20.

Plot of absorbance against time for the reduction of 4.57 micromolar

hemoglobin in pH 7.0, 0. IOM phosphate
0. 509V at 406 nm wavelength.

+ 0. IOM KCl buffer system from 0.589V to -
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Figure 21. Plot of absorbance against time for the reduction of 5.35 micromolar aa
hemoglobin in pH 7 .0, 0. lOM phosphate
0.509V at 406 nm wavelength.

+ 0. lOM KCl buffer system from 0.489V to -
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Figure 22. Plot of absorbance against time for the reduction of 5. 35 micromolar (3(3
hemoglobin in pH 7 .0, 0.10M phosphate
0.509V at 406 nm wavelength.

+ 0.10M KCl buffer system from 0.489V to -
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that, the average reduction time for hemoglobin and its cross-linked products are
different .. Hemoglobin is 92 % reduced in 200 seconds, aa hemoglobin is 92 % reduced
in 250 seconds, and {3{3 hemoglobin is 95 % reduced in 130 seconds. Continuing the
reduction process longer than neccessary leads to a fluctuating absorbance value. The
reason(s) for this behavior might be due to edge diffusion of the solution at the top of the
cell that was used to complete the electrolysis circuit, further reduction of the heme
group adsorption or desorption from the electrode surface, and also the effect of oxygen
since the spectroelectrochemical cell system is not anaerobic.
Figures 23 and 24 show the plot of absorbance against time for the oxidation of
aa, and {3{3 cross-linked hemoglobin respectively. For the oxidation process the potential
was stepped from -0.509V to 0.489V, and -0.609V to 0.589V for aa, and {3{3 crosslinked hemoglobin respectively. The average oxidation time after reduction of the met
forms is 1000 seconds for hemoglobin,

aa, and {3{3 cross-linked hemoglobin. But,

starting with oxy forms and oxidizing to the met forms, it only takes 300 seconds on the
average. The reason for this is unknown. Full oxidation is considerably delayed for the
oxidation of the reduced met forms of hemoglobin and its cross-linked products. This
behavior of delayed oxidation of the reduced met forms was also observed by Daniela
Schlereth et al. 19 This behavior was attributed to possible different redox states of
hemoglobin molecule depending upon the number of heme groups oxidized in the same
molecule. 19 This behavior could also reflect the existence of

single/multilayer of

adsorbed protein molecules onto the electrode surface, making the electrode a chemically
modified electrode and acting as an "electron shuttle" to provide redox coupling between
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Figure 23. Plot of absorbance against time for the oxidation of 5. 35 micromolar aa
hemoglobin in pH 7.0, 0.10M phosphate+ 0.10M KCl buffer system from -0.509V to
0.489V at 406 nm wavelength.
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Figure 24. Plot of absorbance against time for the oxidation of 5.35 micromolar /3/3
hemoglobin in pH 7.0, 0.10M phosphate
0.589V at 406nm wavelength.

+ 0.10M KCl buffer system from -0.609V to
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the electrode and the heme in the protein. Scheller et al proposed the formation of a
multilayer of adsorbed protein which acts in transferring electrons from the electrode to
freely diffusible protein as the mechanism for the electron transfer of myoglobin and
hemoglobin at bare mercury electrodes. 11
Figure 25 shows the cyclic voltabsorptometry plot for the reduction of 5.35
micromolar {3(3 hemoglobin in pH 7.0, 0.10M phosphate

+ 0.10M KCl buffer system

from 0.489V to -0.500V at scan rate of 1 mV/s monitored at 406nm wavelength. During
the reductive process, the absorbance values were relatively constant between potentials
of 0.469V to 0.050V. This corresponds to a period where no electrode reaction occurs.
As the potential is scanned more negative of 0.050V, gradual and steady decrease of
absorbance occurs as the protein is progressively reduced. The drop in absorbance began
in ernest at about -0.125V. The reduction process is essentially complete at -0.335V.
Figure 26 shows the cyclic voltabsorptometry plot for the oxidation of 5. 35
micromolar {3(3 hemoglobin in pH 7.0 0.lM phoshate
-0.509V to 0.489V at

+ 0.lM KCl buffer system from

scan rate of 1 mV/s monitored at 406nm wavelength. The

oxidative process shows a different pattern from the reductive process. Different stages
can be observed. But the stage are not well defined. These stages have been attributed
to three different electrochemical processes in the literature. 19 The rise in absorbance
began at about -0.392V. The true E 0 value of the system must be bracketed by the value
which could be estimated from Figs. 25 and 26, that is, the potential should be between 0.392V to-0.125V. The lack of agreement between the reduction and oxidation scan is
consistent with the results in Figs. 22 and 24 which show that the time scale for
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Figure 25. Cyclic voltabsorptometry plot for the reduction of 5.35 micromolar {3{3
hemoglobin in pH 7.0, 0.lOM phosphate

+

0.lOM KCl buffer system from 0.489V to

-0.500V at scan rate of 1 mV/s monitored at 406nm wavelength.
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Figure 26. Cyclic voltabsorptometry plot for the oxidation of 5.35 micromolar {3(3
hemoglobin in pH 7.0, 0.lM phosphate
0.489V at

+ 0.lM KCl buffer system from -0.509V to

scan rate of 1 mV/s monitored at 406nm wavelength.
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reduction is 130s while the time scale for oxidation is 1000s. In summary, the electron
transfer process at the electrode surface is slow enough that complete equilibrium is not
obtained even at a sweep rate of lmV/s.
Similar results were observed for aa hemoglobin, and uncrosslinked hemoglobin.
The full utility of the thin layer spectroelectrochemistry cell is shown when the potential
is changed gradually in steps.
Figure 27 shows the absorbance spectrum of 2.017 micromolar aa hemoglobin
in pH 7. 0 0. lOM phosphate

+ 0. lOM KCl buffer system at several applied potentials.

The figure shows the absorption spectra associated with small, incremental potential steps
applied to aa crosslinked hemoglobin. The plot shows a gradual decrease in absorbance
peak from -0.113V to -0.413V as the aa hemoglobin is reduced. The absorbance peak
became relatively constant after -0.413V indicating that the reduction is essentially
complete after this potential.
Figure 28 shows the plot of absorbance against potential at 406nm wavelength for
oxyhemoglobin. As the potential is scanned positive of -0.20V, the absorbance value
increases gradually as the hemoglobin is being oxidized from Fe2+ to Fe3 +. The
absorbance values became relatively constant after 0.300V indicating almost complete
oxidation of the hemoglobin.
Figure 29 shows the Nemstian plot obtained for 13.81 micromolar hemoglobin
in pH 7.0, 0.10M phosphate

+ 0. lOM KCl buffer system at 408nm wavelength. In this

plot a straight line was obtained with the slope of 0 .18. The slope gives a n value of
0.33. The theoritical value is 0.01475 for n value of 4. The n value obtained might

77

Figure 27. Absorbance spectrum of 2.017 micromolar aa hemoglobin in pH 7. 0, 0 .1 OM
phosphate

+ 0.10M KCl buffer system at several applied potential:

(a) -0.113V, (b) -0.211V, (c) -0.263V, (d) -0.363V, (e) -0.413V.
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Figure 28. Plot of absorbance against potential for 13.81 micromolar hemoglobin in
pH 7.0, 0.10M phosphate

+ 0.10M KCl

buffer system at 408nm wavelength.
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Fgure 29. Nerstian plot obtained for 13.81 micromolar hemoglobin in pH 7.0, 0.10M
phosphate

+ 0.10M KCI buffer system at 408nm wavelength.
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suggest that true Nemstian conditions have not been fully obtained. It is interesting to
note though, that the n value obtained in the literature is between 1 and 2. 47 · 48 · The
intercept ( E0 '

)

was found to be -0.023V Vs SCE which compares favorably with the

literature value of -0. 070V. 45
Figure 30 shows the plot of absorbance against potential for 13.81 micromolar
aa hemoglobin in pH 7 .0, 0.10M phosphate

+ 0.10M KCl buffer system at 408nm

wavelength. As the potential is scanned positive of -0.363V, the absorbance value
increases gradually as the cm hemoglobin is being oxidized from Fe2+ to FeH. The
absorbance values became relatively constant after 0.15V indicating almost complete
oxidation of the aa hemoglobin.
Figure 31 shows the Nemstian plot obtained
hemoglobin in pH 7. 0, 0. lOM phosphate

for 13.81 micromolar aa

+ 0. lOM KCl buffer system at 408nm

wavelength. Again, a good linear fit was obtained ( r2

=

0.9569). However, the slope

is like that of hemoglobin, close to 0.20V. The intercept yeilds an estimate of E0

=

-0.237V Vs SCE.
From the Nemstian plot of Eapp1. Vs the log of [ox]/ [red], the E0 ' value can be
obtained from the intercept on the y-axis and the slope gives the number of electrons
transferred. The formal potential of hemoglobin, and aa hemoglobin were determined
using the Nernstian plot (Table 1 and 2). The formal potential of {3{3 hemoglobin was
estimated from the cyclic voltabsorptometry plot at scan rate lmV/s (Fig. 25), which
gave a value of -0.201 V. Crosslinking affects both the time for electrolysis and the redox
value measured. Crosslinking enhance the rate of electrolysis of {3{3 crosslinked
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Figure 30. Plot of absorbance against potential for 13. 81 micromolar aa hemoglobin
in pH 7.0, 0.10M phosphate + 0.10M KCl buffer system at 408nm wavelength.
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Figure 31. Nernstian plot obtained for 13.81 micromolar aa hemoglobin in pH 7.0,
0 .1 OM phosphate

+

0 .1 OM KCI buffer system at 408nm wavelength.
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Table 1: Oxy and Met Hemoglobin Experiments
Date
double step

single step

multiple
step

613194

Met-Hb

Data
E, slope, R2 or rate

no A change

619194

Oxy-hb

Comments

A decrease
not increase
619194

success

6/10194

A decrease not
increase

4.17xl0-6 Auls

6/16194

Fluctauting A

6122194

Fluctuating A

6129194 A

Fluctuating A

6129194 B

Success!!

-0. 022 V, 0. 1801 , 0. 964

6130194

Success!!

0.0164 V, 0.1917, 0.94

2/13195 (red)

instrm. error

2/15195 (ox)

fluctuating A

2/15195 B (ox)

fluctuating A

2/15/95 (red)

Success!!

6.25x1Q-5 Auls

2/15195 (ox)

Success!!

5.69xl0-6 Auls

2115195 (ox)

Success!!

1.43xI0-6 Auls

2118195 (?)

?

00
00

0\
00

Table 2: Crossli11kcd I lcmoglohin Experiments.
Date
Double step

J\lpha- Alpha
crosslinkc<l

Single step

Multiple step

Comments

Data
E0 ', Slope, R2 or R

7/16/94

Success

-0.2129, 0.1998, 0.9561

7/27/94

Success

-0.133, 0.1197, 0.6807

2/1 (,/95 (ox)

Success

6.9616 X 10·1 Auls

2/23/95(rc<l)

Success

5.7724 X 10·4 Auls

2/23/95(ox)

Success

7. 9724 X I 0· 1 Auls

2/16/95(ox)

Fluctuating Abs.
7/16/94

Fluctuating Abs.

7/I 6/94(nxl)

8/1/95
Beta-Beta
crosslinkc<l

Fluctuating Abs.

Abs. decrease not
increase
Fluctuating Abs.

2/5/95(rcd)

1.164 X 10·4 Auls

2/l l/95(rcd)
Decrease not
increase

2/l l/95(ox)
2/22/95

Fluctuating Abs.

2/22/95(ox)

6.759 X 10·1 Auls

2/22/95(rcd)

3.870 X 10·4 Auls
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hemoglobin substantially.
Table 1 shows the various attempts made at obtaining the E0 ' values for
hemoglobin and also to find out how long it takes to oxidized and reduce hemoglobin at
an unmodified electrode.
Table 2 shows the values obtained for the cross-linked hemoglobin products. It
generally takes a shorter time to run {3{3 crosslinked hemoglobin experiments.
Hemoglobin experiments are very difficult to run because any slight change in
experimental conditions might lead to fluctuating absorbance values or the absorbance
values might go in the opposite direction.
The shift to a negative potential implies that the crosslinked forms of
oxyhemoglobin preferentially stabilize the trivalent iron (met heme).
Figures 32 and 33, show the deoxycrystal structures of aa and {3{3 crosslinked
hemoglobin respectively. The X-ray crystallographic studies of aa and {3{3 crosslinked
hemoglobin suggest some movements of the amino acid residues within the central cavity
of the tetramer. 46 This movement might be responsible for the preference of the heme
in the

+ 3 oxidation state as compared to the native hemoglobin, thus stabilizing it. The

protein moiety influences both the redox potential and the electrochemical behavior of
the prosthetic groups inside a protein. The following are the characteristic features of
electrode reaction of hemoglobin and other proteins (myoglobin, etc) that has been noted
by myself and other reseachers 45 :
1. Hemoglobin and its cross-linked products are strongly adsorbed at the

electrode-electrolyte solution interface. 45
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Figure 32. Molecular modelling structure for aa hemoglobin (Adapted from Fernandez
d 1ssertation with permissiom46).
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Figure 33. Molecular modelling structure for {3(3 hemoglobin (Adapted from Fernandez
dissertation with permissiom46).
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2. Adsorption at an electrode surface may lead to conformational changes or to
a complete denaturation of the adsorbed protein, as found at other interfaces. 45 .
3. The protein/hemoglobin concentration at the electrode is increased m
comparison with the bulk solution, when protein or hemoglobin is adsorbed at the
electrode surface. 45
4. Diffusion of the macromolecule is slow, therefore only very small or no
Faradaic currents may be measured. 45
5. The reducible or prosthetic groups of the protein constitute only a very small
part of the molecular surface; thus the interaction with the electrode is sterically
hindered.

In most cases, electroactive groups are "buried" by the isolating protein

fabric. 45
The

following

additional

observations

concerning

the

spectroelectrochemicalexperiments of hemoglobin and its cross-linked products has been
made by myself:
1. It is extremely important to have a reproduceable electrode surface to obtain
consistent results .
2. The sensitivity of the spectrophotometer is also crucial since absorbance values
of the protein is very small.
3. Reproducible experimental conditions such as cell volume, optical light path,
and a clean spectroelectrochemical cell surface (especially the outside surface) are very
important.
4. Crosslinking of the hemoglobin affects the time scale of the electrochemical
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reduction and oxidation.
5. Crosslinking of the hemoglobin results in a conformation which favors Fe (III)
oxidation state.

CHAPTER 4
SUMMARY AND FUTURE DIRECTION

In this project, the design and construction of optically transparent thin-layer cell
has been described. Electrochemical and thin-layer spectroelectrochemical behavior of
the cell were confirmed by using ferri/ferrocyanide as the test system.
Using the spectroelectrochemical system, hemoglobin, lysine (99)ai-lysine (99)a2
cross-linked hemoglobin, and lysine (82)/3i-lysine (82)/32 cross-linked hemoglobin, were
reduced and oxidized at an unmodified platinum gauze electrode with the reduction rate
being faster than the oxidation rate. The system was also used to determine the E 0 ' values
for hemoglobin and its cross-linked products. The E 0 ' values of aa, and /3/3 cross-linked
hemoglobin are more negative than uncrosslinked hemoglobin indicating preference of
the crosslinked products for the

+ 3 oxidation state. The conformation/configuration of

hemoglobin and its crosslinked products at the electrode surface play a role in their
electrochemical behavior.
Spectroelectrochemical studies only employs a small amount of solution for
obtaining electrochemical parameters and properties of redox processes. This will benefit
electrochemical research in which small samples are available, such as crown ether
complexes and anticancer pharmaceuticals.
97
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In the future, there is a need to construct a system that is completely anaerobic.
Deoxyhemoglobin could be studied with the anaerobic system. The spectroscopy and
electrochemistry need to be controlled through interfaces from data acquition and
treatment software. None is available in the market at present. The software program
should be capable of runing different types of spectroelectrochemical experiments such
as double step voltabsorptometry, cyclic voltabsorptometry, and potential step
voltabsorptometry experiments.

APPENDIX 1
WORK NOT PRESENTED IN THESIS
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Other projects that I worked on during the course of my time at Loyola University
included the electrochemical behavior of myoglobin. The research conducted on this
protein laid the groundwork for subsequent work done on hemoglobin.
Myoglobin, the small heme protein (molecular weight 17800) found primarily in
cardiac and red skeletal muscles, functions physiologically in its reduced state to store
dioxygen and facilitate its transport to the mitochondria. Myoglobin has been used in the
literature as a model compound to study the dioxygen-binding properties of the larger ,
more complex hemoglobin. 48 Literature shows that myoglobin and hemoglobin have
similar electrochemical behavior. 49
Preliminary studies show that small current signal was observed for myoglobin
with the cathodic peak current being larger than anodic peak current. But the signal
obtained is nearly a reversibly cyclic voltammogram. The addition of a mediator
compound (methylene blue), which on its own shows a well developed asymmetric peak
with a slightly sharper anodic peak current, did not increase the signal, but sharpens the
anodic peak of the methylene blue drastically. The following results were also obtained:
( 1)

The most ideal scan rate for running the CV is between 16 and 25 mV / s.

(2)

Myoglobin shows best reversibility at 16 and 20 mV/s, Ipc/ Ipa which is a
measure of reversibility is equal to 1.

(3)

The cathodic peak current for myoglobin in methylene blue is less than or
equal to the sum of individual cathodic peak currents.

(4)

The anodic peak current for myoglobin in methylene blue is enhanced, the
observed peak current is far greater than individual peak currents.
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(5)

Peak current increases with increase in pH for myoglobin in methylene
blue, and methylene blue. In the case of myoglobin, it increases up to pH
5.85 but lowest current was observed at pH 6.24.

Experimental works with chemically modified electrodes did not yield any new results
from the ones obtained for mediator compounds added to the solution containing
myoglobin. But new problems were observed such as desorption of the mediator
compounds from the surface of the electrode. The current signals, both cathodic and
anodic, are generally smaller than those obtained for the mediator compound in solution
with the myoglobin.
Different electrodes, such as glass doped indium tin oxide electrode, platinum
wire electrode, glassy carbon electrode, were used to study electrochemical behavior of
myoglobin.

The best result was obtained using glassy carbon electrode. All the

observations mentioned above were obtained using glassy carbon electrode and saturated
calomel electrode as the reference.
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